Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
- DOI
- 10.1093/eurheartj/ehaf676
- Published
- 2026 May 5
- Container
- European heart journal
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/eurheartj/ehaf676,
title = {Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.},
author = {Lurz P and Hahn RT and Kodali S and Makkar R and Sharma RP and Davidson CJ and O'Neill BP and Yadav P and Zahr F and Chadderdon S and Eleid MF and Szerlip M and Smith RL and Whisenant B and Garcia S and Kister T and Kipperman RM and Lim DS and Saxon J and Kapadia S and Hermiller J and Mishell JM and Rassi A and Herrmann HC and Szeto W and Hausleiter J and Babaliaros V and Barker CM and Lindman BR and Latib A and Muhammad K and von Bardeleben RS and Summers M and Chetcuti SJ and Ailawadi G and Russo M and Rinaldi M and Chehab BM and Nickenig G and Stinis C and Inglessis-Azuaje I and Dhoble A and Chhatriwalla AK and Petrossian G and Shah P and Staniloae C and Williams M and Nores M and McCabe JM and Singh G and Baldus S and Rudolph V and Barb I and Klodell C and Gray W and Strote J and Sannino A and Grayburn P and Mack MJ and Leon MB and Thourani VH},
year = {2026},
journal = {European heart journal},
doi = {10.1093/eurheartj/ehaf676},
url = {https://doi.org/10.1093/eurheartj/ehaf676}
}RIS
TY - JOUR TI - Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial. AU - Lurz P AU - Hahn RT AU - Kodali S AU - Makkar R AU - Sharma RP AU - Davidson CJ AU - O'Neill BP AU - Yadav P AU - Zahr F AU - Chadderdon S AU - Eleid MF AU - Szerlip M AU - Smith RL AU - Whisenant B AU - Garcia S AU - Kister T AU - Kipperman RM AU - Lim DS AU - Saxon J AU - Kapadia S AU - Hermiller J AU - Mishell JM AU - Rassi A AU - Herrmann HC AU - Szeto W AU - Hausleiter J AU - Babaliaros V AU - Barker CM AU - Lindman BR AU - Latib A AU - Muhammad K AU - von Bardeleben RS AU - Summers M AU - Chetcuti SJ AU - Ailawadi G AU - Russo M AU - Rinaldi M AU - Chehab BM AU - Nickenig G AU - Stinis C AU - Inglessis-Azuaje I AU - Dhoble A AU - Chhatriwalla AK AU - Petrossian G AU - Shah P AU - Staniloae C AU - Williams M AU - Nores M AU - McCabe JM AU - Singh G AU - Baldus S AU - Rudolph V AU - Barb I AU - Klodell C AU - Gray W AU - Strote J AU - Sannino A AU - Grayburn P AU - Mack MJ AU - Leon MB AU - Thourani VH PY - 2026 JO - European heart journal DO - 10.1093/eurheartj/ehaf676 UR - https://doi.org/10.1093/eurheartj/ehaf676 ER -
APA
P, L., RT, H., S, K., R, M., RP, S., CJ, D., BP, O., P, Y., F, Z., S, C., MF, E., M, S., RL, S., B, W., S, G., T, K., RM, K., DS, L., J, S., S, K., J, H., JM, M., A, R., HC, H., W, S., J, H., V, B., CM, B., BR, L., A, L., K, M., RS, V. B., M, S., SJ, C., G, A., M, R., M, R., BM, C., G, N., C, S., I, I., A, D., AK, C., G, P., P, S., C, S., M, W., M, N., JM, M., G, S., S, B., V, R., I, B., C, K., W, G., J, S., A, S., P, G., MJ, M., MB, L., & VH, T. (2026). Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.. European heart journal. https://doi.org/10.1093/eurheartj/ehaf676
Source records
- pubmed · retrieved 2026-09-26T03:33:42.134Z